This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Tyme Technologies Management
Management Kriterienprüfungen 3/4
Wichtige Informationen
Richie Cunningham
Geschäftsführender
US$1.3m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 42.0% |
| Amtszeit als Geschäftsführer | 1.8yrs |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 2.7yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 6.1yrs |
Jüngste Management Updates
Recent updates
Syros, Tyme Technologies jump more than 20% after hours as shareholders approve merger
Sep 15We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Aug 05
TYME stock surges on merger agreement and Syros Pharmaceuticals
Jul 05Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives
May 26We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Mar 19Tyme Technologies Offers Incredible Risk-Reward
Dec 07Here's Why We're Not Too Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Nov 19Tyme Technologies: The Market Missed The Bullish Memo
Aug 27We're Not Very Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate
Jul 19Tyme Technologies reports FY results
Jun 10Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount
May 29Here's Why We're Watching Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Mar 26Have Tyme Technologies, Inc. (NASDAQ:TYME) Insiders Been Selling Their Stock?
Feb 19
Tyme falls after equity offer as quarterly data indicate liquidity pressure
Feb 04Tyme stock granted U.S. patent claims for using TYME-19 to treat COVID-19 infections
Feb 03Do Institutions Own Tyme Technologies, Inc. (NASDAQ:TYME) Shares?
Feb 02Revisiting Tyme Technologies
Dec 17Have Insiders Sold Tyme Technologies, Inc. (NASDAQ:TYME) Shares Recently?
Dec 16Is Tyme Technologies (NASDAQ:TYME) In A Good Position To Invest In Growth?
Dec 09Tyme Technologies names new finance chief
Nov 30Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$24m |
| Mar 31 2022 | US$1m | US$564k | -US$24m |
| Dec 31 2021 | n/a | n/a | -US$24m |
| Sep 30 2021 | n/a | n/a | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | US$2m | US$194k | -US$29m |
Vergütung im Vergleich zum Markt: Richie's total compensation ($USD1.34M) is above average for companies of similar size in the US market ($USD765.87K).
Entschädigung vs. Einkommen: Richie's compensation has been consistent with company performance over the past year.
Geschäftsführer
Richie Cunningham (51 yo)
1.8yrs
Amtszeit
US$1,344,080
Vergütung
Mr. Richard Cunningham, also known as Richie, serves as Chief Executive Officer and Director at Tyme Technologies, Inc. since November 23, 2020. Mr. Cunningham had been the Chief Executive Officer and Pres...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.34m | keine Daten | |
| Co-Founder & Director | 9.2yrs | US$2.60m | 11.63% $ 6.2m | |
| Chief Financial Officer | 1.3yrs | US$1.29m | 0.0058% $ 3.1k | |
| Chief Legal Officer & Secretary | 4yrs | US$1.19m | 0.061% $ 32.7k | |
| Chief Business Officer | 3.5yrs | US$858.79k | keine Daten | |
| Acting Chief Medical Officer | 1.4yrs | keine Daten | 0.0057% $ 3.1k |
2.7yrs
Durchschnittliche Betriebszugehörigkeit
58yo
Durchschnittliches Alter
Erfahrenes Management: TYME's management team is considered experienced (2.7 years average tenure).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$1.34m | keine Daten | |
| Co-Founder & Director | 7.5yrs | US$2.60m | 11.63% $ 6.2m | |
| Independent Director | 7.5yrs | US$138.73k | 0.0034% $ 1.8k | |
| Independent Director | 4.3yrs | US$146.99k | keine Daten | |
| Independent Chairman | 3.9yrs | US$166.34k | 0.064% $ 34.2k | |
| Independent Director | 5.5yrs | US$148.24k | 0.058% $ 31.1k | |
| Independent Director & Member of Medical Advisory Board | 7.5yrs | US$122.87k | 0.0034% $ 1.8k | |
| Member of Medical Advisory Board | 6.7yrs | keine Daten | keine Daten | |
| Member of Medical Advisory Board | no data | keine Daten | keine Daten | |
| Member of Medical Advisory Board | no data | keine Daten | keine Daten | |
| Member of Medical Advisory Board | no data | keine Daten | keine Daten | |
| Member of Medical Advisory Board | no data | keine Daten | keine Daten |
6.1yrs
Durchschnittliche Betriebszugehörigkeit
65yo
Durchschnittliches Alter
Erfahrener Vorstand: TYME's board of directors are considered experienced (6.1 years average tenure).